Infusion-related complaints during or the first 24 hours after infusion, and side-effects during 12 months follow-up, in the Rituximab and Placebo groups.
收藏NIAID Data Ecosystem2026-03-07 收录
数据链接：
官方服务：
资源简介：
Infusion-related complaints during or the first 24 hours after infusion, and side-effects during 12 months follow-up, in the Rituximab and Placebo groups.
创建时间：
2011-10-19
